Medication for OCD: Why the Dose and the Wait Matter More Than the Brand

Maybe you’ve been on an SSRI for a month and the checking hasn’t budged. Maybe someone told you medication “didn’t work” after one short try at a starting dose. If so, it’s worth knowing that OCD plays by different medication rules than depression.

OCD involves differences in the frontal cortex and deeper brain structures that help control behavior. The medications that work best target serotonin, a chemical messenger NIMH describes as involved in both depression and OCD. In OCD, the response to these medications depends heavily on dose and time. Getting both right takes precision.

The medications themselves have a strong track record. Serotonin reuptake inhibitors are the only medications FDA-approved for OCD, and a network meta-analysis found SSRIs as a class outperformed placebo across 37 trials and 3,158 patients. The evidence is solid, and these drugs have helped people for decades.

The medications haven’t changed, but the way they’re often prescribed for OCD hasn’t caught up with the evidence, and at Siggy we think every medication deserves a fair trial before anyone calls it a failure.

A fair OCD trial is defined by dose and time: an SSRI raised toward the higher end of its range, held long enough to judge, with progress measured rather than guessed. It uses the same medications with more care, and it follows from how OCD responds to serotonin, which is a matter of pharmacology.

What This Page Covers

• Which Medications Are FDA-Approved for OCD?
• Is One SSRI Better Than the Others for OCD?
• Why Does OCD Often Need a Higher Dose?
• How Long Should You Give a Medication?
• What Side Effects Should You Expect?
• What If the First SSRI Does Not Work?
• How Long Do People Stay on OCD Medication?
• How Siggy Fits In
• Make Your Next Medication Conversation Count

Which Medications Are FDA-Approved for OCD?

Five medications carry FDA approval for OCD, according to IOCDF medication guidance, and two more SSRIs are used off-label:

Medication	Type	FDA-Approved for OCD
Fluoxetine (Prozac)	SSRI	Yes
Fluvoxamine (Luvox)	SSRI	Yes
Paroxetine (Paxil)	SSRI	Yes
Sertraline (Zoloft)	SSRI	Yes
Clomipramine (Anafranil)	Tricyclic	Yes
Citalopram, escitalopram	SSRI	No, used off-label

Off-label means the FDA hasn’t approved a drug for that specific use, though a prescriber can still choose it. The IOCDF notes that data support citalopram and escitalopram for OCD and that they appear as effective as the other SSRIs. Escitalopram is approved for OCD in Europe. For a closer look at one option, see our guide to fluvoxamine for OCD and anxiety.

Is One SSRI Better Than the Others for OCD?

No SSRI has proven best. The IOCDF notes that head-to-head trials found very similar efficacy across SSRIs, and that the belief that fluvoxamine works best for OCD traces back to marketing rather than data.

So the choice usually comes down to you. Prescribers weigh side-effect profiles, drug interactions, how you or a family member responded to an SSRI before, your preferences, and how long each drug stays in your system. That’s why it helps to share your full medication history, including what didn’t work and why.

Why Does OCD Often Need a Higher Dose?

This is the biggest difference from depression treatment. In a dose-response meta-analysis including 2,268 adults with OCD, higher SSRI doses were more effective than low or medium doses. The authors noted this pattern stands in contrast to depression.

There’s a tradeoff. In the same analysis, higher doses led to more people stopping because of side effects. The IOCDF adds that doses up to two to three times those typically used for depression tend to give the greatest benefit for OCD.

You can see this in sertraline’s own trials. In sertraline’s prescribing information, two flexible-dose OCD trials had average doses of about 185 mg per day among people who completed them, close to the 200 mg label maximum. The IOCDF’s description of an adequate OCD trial includes sertraline doses of 200 to 300 mg per day, which goes above the label maximum. That’s off-label and calls for close monitoring.

How Long Should You Give a Medication?

Longer than most people expect. NIMH’s OCD guide notes that antidepressant treatment can take 8 to 12 weeks before symptoms begin to improve. The IOCDF defines an adequate trial as 8 to 12 weeks, with at least 6 of those weeks at a moderate to high dose, and notes that improvement can continue past 12 weeks.

Early change still matters. A time-course meta-analysis found the greatest incremental gains happened early in treatment. Small early shifts, like rituals taking a little less time, are worth tracking and reporting.

Questions worth asking at the start of any OCD medication trial:

• What dose are we aiming for, and how quickly will we get there?
• How long will we hold that dose before deciding?
• How will we measure whether it’s working?
• What’s the plan if it isn’t enough?

Patience pays off at the next step too. An augmentation review found that 25.6% of people responded simply by continuing their serotonin reuptake inhibitor, and recommended at least 3 months at the maximum tolerated dose before adding an antipsychotic.

What Side Effects Should You Expect?

NIMH lists headaches, nausea, and trouble sleeping as possible side effects. In sertraline’s pooled trials across conditions, nausea affected 26% of people versus 12% on placebo, and diarrhea affected 20% versus 10%. Insomnia and agitation were among the most common side effects specific to the OCD trials.

Sexual side effects deserve an honest conversation. The same label reports ejaculation failure in 8% of men on sertraline versus 1% on placebo, and decreased libido in both men and women. Many early side effects ease within a few weeks, but persistent ones are a reason to talk with your prescriber rather than quietly stop. Our guide to SSRI sexual side effects covers practical options.

What If the First SSRI Does Not Work?

About 40% to 60% of people with OCD have a clinically significant response to their first SSRI trial, according to the IOCDF. If yours didn’t help enough, the first step is checking that the dose and timing were adequate and that the medication was taken consistently. Other conditions that might block a response also deserve a look.

From there, the IOCDF describes these common paths:

• Starting or increasing exposure and response prevention (ERP)
• Switching to a different SSRI, though the odds of response appear 10% to 20% lower than with the first
• Switching to clomipramine after one or two SSRI trials
• Adding a low-dose antipsychotic, with aripiprazole and risperidone having the most evidence

Clomipramine is effective but harder to take. In Anafranil’s prescribing information, adults on clomipramine improved by 35% to 42% on a standard OCD scale, while people on placebo showed no important response. The IOCDF notes common side effects like dry mouth, constipation, and weight gain, plus the need for blood levels and periodic ECGs to check heart rhythm.

Before adding an antipsychotic, consider ERP. In a randomized augmentation trial, 80% of people already on medication responded when ERP was added, compared with 23% for risperidone and 15% for placebo. Our guide to how to treat OCD covers ERP in depth.

How Long Do People Stay on OCD Medication?

Often a long time, and that’s by design. The IOCDF notes that relapse is high when people stop SSRIs for OCD, so long-term treatment is commonly recommended. It also notes that ERP may lower the risk of relapse after medication is stopped.

The data back this up. In a sertraline relapse-prevention trial described in the prescribing information, people who had responded and stayed on sertraline had significantly lower rates of relapse or insufficient response over 28 weeks than those switched to placebo. NHS treatment guidance notes that most people need treatment for at least a year.

When it’s time to stop, don’t do it suddenly. The label recommends reducing the dose gradually, and our guide to tapering off Zoloft explains how a careful taper works.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including OCD and the anxiety and depression that often occur alongside it. NIMH notes it’s common for people with OCD to also have a mood or anxiety disorder.

If you’re already taking an SSRI from another clinician, Siggy can help you organize what’s happened so far. The anonymous intake needs no name, email, or account, and you’ll get a downloadable summary covering your symptoms, past medications, doses, and side effects. That record makes it easier to ask whether your trial has been long enough and high enough. If OCD, anxiety, or depression is part of the picture, a licensed prescriber reviews your full intake before anything is prescribed.

Siggy isn’t an emergency service. If you’re in crisis, call 911 or 988 first. Never change or stop a medication without talking to your prescriber. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

Make Your Next Medication Conversation Count

OCD medication works best when the dose is right, the wait is long enough, and someone is paying attention to how you’re actually doing. A clear history of what you’ve tried is the fastest way to get there, and our guide to signs your antidepressant dose is too low can help you spot what to raise. Start your anonymous intake and bring your summary to your next appointment. It’s free, a real doctor reviews every clinical decision, and the record is yours to keep.